NYMPHSYN MAXIMIZER

Manufacturer
ULAB | U-LAB Switzerland AG
Effective date
2017-03-22
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:49:21

Label at a glance#

ProductNYMPHSYN MAXIMIZER
Active ingredientGLYCERIN
Label structure8 sections

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Active ingredients: GLYCERIN 6.29%

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

Inactive ingredients: AQUA (WATER), C12-20 ACID PEG-8 ESTER, CAPRYLIC/CAPRIC TRIGLYCERIDE, BUTYLENE GLYCOL, CYCLOPENTASILOXANE, CETYL ALCOHOL, PHENOXYETHANOL, POTASSIUM CETYL PHOSPHATE DIMETHICONE, CARBOMER, SODIUM POTASSIUM ALUMINUM SILICATE ETHYLHEXYLGLYCERIN, DIMETHICONOL, SODIUM HYDROXIDE, PARFUM (FRAGRANCE), CI 77891 (TITANIUM DIOXIDE), DISODIUM EDTA, MICA, PPG-25-LAURETH-25, SILICA, PALMITOYL TRIPEPTIDE-5, PEG-8, TRITICUM VULGARE (WHEAT) PROTEIN, PENTYLENE GLYCOL, SODIUM HYALURONATE, TOCOPHEROL, ASCORBYL PALMITATE, ASCORBIC ACID, CITRIC ACID, NICOTIANA SYLVESTRIS LEAF CELL CULTURE, SODIUM DEHYDROACETATE, SORBIC ACID, UNDECYLENIC ACID

PURPOSE

OTC - PURPOSE SECTION

Purpose: Moisturizing and lifting for youthful appearance

WARNINGS

WARNINGS SECTION

Warnings: For external use only Avoid eye contour area Discontinue use if signs of irritation or rashes appear.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN

INDICATIONS & USAGE

INDICATIONS & USAGE SECTION

Indications & Usage: Apply morning and night

DOSAGE & ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Dosage & Administration: Apply morning and night to face and neck after serum and ampoule

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
GLYCERIN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-137640151210458GTIN-13: 7640151210458
EAN-13: 7640151210458
GTIN storage (14 digits): 07640151210458
nymphsyn maximizer cream carton.jpg

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
71276-060-022020-01-31C16284748780-19d75b9cf-d2a1-f424-e053-dadaa90a57cef012a6eb-e0d6-4aa2-baa7-ef5c1db796e5

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71276-060-01NYMPHSYN MAXIMIZER50 mL in 1 BOTTLE, PUMPCREAM501
71276-060-02NYMPHSYN MAXIMIZER1 in 1 CARTONCREAM11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71276-060NYMPHSYN MAXIMIZER (GLYCERIN) CREAM [ULAB]1Legacy NDC, 2 package rows20170322_f012a6eb-e0d6-4aa2-baa7-ef5c1db796e5.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71276-06071276-060-01, 71276-060-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
GLYCERINPDC6A3C0OXACTIB
WATER059QF0KO0RIACT
C12-20 ACID PEG-8 ESTER9M7A3K4339IACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
10da585a-3e5b-4a0a-b958-43e26013c018f012a6eb-e0d6-4aa2-baa7-ef5c1db796e52017-03-22WarningsExact identifier
spl id: 10da585a-3e5b-4a0a-b958-43e26013c018
spl set id: f012a6eb-e0d6-4aa2-baa7-ef5c1db796e5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.